Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 1

Conditions

Polycystic Ovary Syndrome 1Oligodendroglioma 1Neoplasms 1Glucose Metabolism Disorders 1Glucose Intolerance 1Glioblastoma 1Fatty Liver 1Astrocytoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Proton Magnetic Resonance Spectroscopy × Clear all
NCT00645385 2019-06-04

Gliadel-MRS

Weill Medical College of Cornell University

Withdrawn
CNS

Astrocytoma, Glioblastoma, Neoplasms, Oligodendroglioma

NCT03204461 2017-07-02

Glucose Metabolism in Different PCOS Phenotypes

Medical University of Vienna

Completed
73 enrolled

Fatty Liver, Polycystic Ovary Syndrome, Glucose Intolerance, Glucose Metabolism Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡